Ferrucci, Veronica
Miceli, Marco
Pagliuca, Chiara
Bianco, Orazio
Castaldo, Luigi
Izzo, Luana
Cozzolino, Marica
Zannella, Carla
Oglio, Franca
Polcaro, Antonio
Randazzo, Antonio
Colicchio, Roberta
Galdiero, Massimiliano
Berni Canani, Roberto
Salvatore, Paola
Zollo, Massimo http://orcid.org/0000-0002-0970-7243
Article History
Received: 14 March 2024
Accepted: 6 June 2024
First Online: 17 June 2024
Declarations
:
: The Ethical Committee approvals for the COVID19 samples use in this study were as follows: (i) protocol no. 141/20; date: 10 April 2020, CEINGE TaskForce Covid19; Azienda Ospedaliera Universitaria Federico II, Direzione Sanitaria, protocol no. 000576 of 10 April 2020; (ii) protocol no. 157/20; date: 22 April 2020, GENECOVID, with the experimental procedures for the use of SAR-CoV-2 in a biosafety level 3 (BSL3) laboratory were authorized by Ministero della Sanità and Dipartimento Di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II and Azienda Ospedaliera Universitaria Federico II, Direzione Sanitaria protocol no. 0007133 of 08 May 2020; (iii) protocol no. 18/20; date: 10 June 2020, Genetics CEINGE TaskForce Covid19; Azienda Ospedaliera Universitaria Federico II, Direzione Sanitaria protocol no. 000576 of 10 April 2020.
: The manuscript does not contain data from any individual person.
: The authors declare no competing interests.